MONUMENT ADVOCACY

MONUMENT ADVOCACY filed a Q2 report for MCKESSON CORPORATION on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for MCKESSON CORPORATION · Provider of medicines, pharmaceutical supplies and health IT products & services.

All filings by MONUMENT ADVOCACY · Everything MCKESSON CORPORATION has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

ECAPS and Main Street Pharmacy Act; AI for clinical care; Protecting Patient Access to Cancer and Complex Therapies Act (Murphy)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.